文献速递胰腺与胆道疾病消化道肿瘤与早癌

慢性胰腺炎相关基因胚系变异与胰腺导管腺癌风险

Germline Variants in Chronic Pancreatitis-Associated Genes and Risk of Pancreatic Ductal Adenocarcinoma.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-04-20

在4528例胰腺导管腺癌(PDAC)患者和52659例无PDAC对照中进行胚系全外显子组测序,评估11个慢性胰腺炎相关基因的致病性胚系变异与PDAC风险的关联。PRSS1和CFTR与PDAC风险相关,PRSS1信号主要由p.Arg122His变异驱动,CFTR有6个变异显著相关。

要点

  • PRSS1和CFTR与胰腺导管腺癌风险相关
  • PRSS1关联主要由p.Arg122His变异驱动,OR为72.34
  • 多数携带CFTR变异的PDAC患者无临床诊断的慢性胰腺炎

核心结论

  • 在慢性胰腺炎相关基因中,PRSS1和CFTR的罕见致病性胚系变异与胰腺导管腺癌风险相关。

研究设计与样本

  • 对4528例PDAC病例和52659例无PDAC对照进行胚系全外显子组测序。
  • 采用基于基因的负荷分析识别PDAC相关基因,并对显著基因进行变异水平分析。
  • 使用逻辑回归计算比值比(OR)和95%置信区间(CI),调整年龄、性别和祖先主成分。

主要发现

  • PRSS1与PDAC风险相关(P < .001),CFTR与PDAC风险相关(P = .008)。
  • PRSS1关联主要由p.Arg122His变异驱动,该变异与显著升高的风险相关(OR,72.34;P < .001)。
  • 6个CFTR变异与PDAC显著相关,其中5个的风险估计(OR)范围为3.66至10.21。
  • 大多数携带CFTR变异的PDAC病例缺乏临床诊断的慢性胰腺炎,而大多数PRSS1变异携带者无PDAC家族史。

临床怎么用

  • 若在更大规模研究中得到证实,这些发现可能有助于指导PDAC患者的胚系检测策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Hereditary chronic pancreatitis (CP) is associated with elevated risk of pancreatic ductal adenocarcinoma (PDAC), but the specific contributing genes and their associated risk magnitudes remain incompletely defined. We aimed to investigate whether pathogenic germline variants (PGVs) in all 11 known CP-associated genes (CASR, CEL, CFTR, CLDN2, CPA1, CPB1, CTRC, PNLIP, PRSS1, SPINK1, TRPV6) predispose to PDAC and to quantify their risk estimates. METHODS: Germline whole-exome sequencing was performed among 4528 PDAC cases and 52,659 controls without PDAC. Gene-based burden analyses were performed to identify PDAC-associated genes, followed by variant-level analyses of significant genes to determine the primary contributors to the gene-level associations. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression, adjusting for age, sex, and ancestry principal components. RESULTS: PRSS1 (P < .001) and CFTR (P = .008) were associated with PDAC risk. The PRSS1 association was driven primarily by the p.Arg122His variant, which was associated with markedly elevated risk (OR, 72.34; P < .001). Six CFTR variants were significantly associated with PDAC, 5 of which had risk estimates (OR) ranging from 3.66 to 10.21. Most PDAC cases carrying CFTR variants lacked clinically diagnosed CP, whereas most PRSS1 variant carriers did not have a family history of PDAC. CONCLUSIONS: Among CP-associated genes, rare PGVs in PRSS1 and CFTR are associated with PDAC risk. The PRSS1 signal was driven mainly by p.Arg122His, whereas the CFTR association involved 6 variants, with 5 having clinically relevant risk magnitudes. If confirmed in larger studies, these findings could help inform germline testing strategies in patients with PDAC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Antwi SO, Rabe KG, Carlson EE, et al. Germline Variants in Chronic Pancreatitis-Associated Genes and Risk of Pancreatic Ductal Adenocarcinoma. Clin Gastroenterol Hepatol. 2026. PMID: 42019862. doi:10.1016/j.cgh.2026.03.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。